Cartesian Therapeutics
RNAC
#8958
Rank
A$0.28 B
Marketcap
A$9.28
Share price
4.24%
Change (1 day)
-17.25%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -A$78.87 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are A$1.47 Million. In 2025 the company made an earning of -A$74.05 Million a decrease over its 2024 earnings that were of -A$41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$78.87 Million6.52%
2025 -A$74.05 Million80.63%
2024 -A$41 Million-88.5%
2023 -A$0.36 Billion-724%
2022 A$57.1 M-649.67%
2021 -A$10.39 Million-89.78%
2020 -A$0.11 Billion25.06%
2019 -A$81.33 Million-15.68%
2018 -A$96.46 Million-0.43%
2017 -A$96.87 Million83.41%
2016 -A$52.82 Million44.3%
2015 -A$36.61 Million